142nd APHA Annual Meeting and Exposition

Annual Meeting Recordings are now available for purchase

309132
Reaching in to reach out: Unique program locates Buprenorphine treatment in two Baltimore City grassroots recovery programs

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual
Monday, November 17, 2014

Pia M. Mauro , Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
Deborah Agus, JD
Michael Fingerhood, MD MPH
Background: Opioid use dependence is a major public health concern highlighted by recent high profile heroin-related deaths. Barriers to care remain for individuals in impoverished urban areas due to lack of engagement, distrust in the traditional system and lack of insurance. The Behavioral Health Leadership Institute (BHLI) buprenorphine program employs a unique, flexible model that engages community members where they live. Methods: 305 clients from two Baltimore City sites were recruited in 2010-2013. Active clients (n=24) or incarcerated (n=11) were excluded; 7 were readmissions. Participants had a mean age of 46.7±0.5 years; 60.0% were men, 83.0% Black/African-American, 81.6% unemployed, 49.5% unstably housed, and 35.4% had no primary care provider. More than half (58.0%) had chronic illnesses, 8.9% HIV+, and 20.7% HCV+. T-tests and chi-squared tests assessed associations between client characteristics and treatment status: transitioned to ongoing care (transitioned) and lost to follow-up (LTF). Logistic regression calculated the odds of transition by client characteristics. Results: 41.6% of clients were transitioned to ongoing care. Mean treatment length was 70 days longer for transitioned (116.9 days) than LTF (46.7 days) (t=9.1, df=300, p<0.001). Odds of transition increased by 13% with each week of participation (OR=1.13, 95% CI=1.09-1.17, p<0.001). Individuals with chronic illnesses or HIV+ had higher odds of transition (p’s<0.05). Demographic variables were not associated with transition. Conclusions: Buprenorphine treatment can be incorporated into trusted grassroots recovery programs to reach individuals in their communities. Flexible programs that engage low-resource communities in impoverished neighborhoods can be used to address current gaps in services.

Learning Areas:

Conduct evaluation related to programs, research, and other areas of practice
Diversity and culture

Learning Objectives:
Evaluate treatment retention and completion in two buprenorphine grassroots Baltimore City recovery programs. Compare characteristics of clients who were transitioned to ongoing services to those who were lost to follow-up.

Keyword(s): Drug Abuse Treatment, Drug Abuse

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have been working with the Behavioral Health Leadership Institute (BHLI) as a Research Associate evaluating the ongoing Buprenorphine Program for over two years. I am also a PhD candidate and a NIDA Drug Dependence Epidemiology Training (DDET) fellow.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.